Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 30, 2025 | 239.44 |
| December 29, 2025 | 207.27 |
| December 26, 2025 | 359.37 |
| December 24, 2025 | 363.47 |
| December 23, 2025 | 358.74 |
| December 22, 2025 | 365.25 |
| December 19, 2025 | 352.11 |
| December 18, 2025 | 345.18 |
| December 17, 2025 | 349.07 |
| December 16, 2025 | 360.94 |
| December 15, 2025 | 380.81 |
| December 12, 2025 | 380.81 |
| December 11, 2025 | 380.49 |
| December 10, 2025 | 378.39 |
| December 09, 2025 | 381.54 |
| December 08, 2025 | 383.12 |
| December 05, 2025 | 382.39 |
| December 04, 2025 | 384.07 |
| December 03, 2025 | 383.12 |
| December 02, 2025 | 351.80 |
| December 01, 2025 | 350.75 |
| November 28, 2025 | 365.25 |
| November 26, 2025 | 354.85 |
| November 25, 2025 | 352.38 |
| November 24, 2025 | 344.55 |
| Date | Value |
|---|---|
| November 21, 2025 | 353.06 |
| November 20, 2025 | 327.73 |
| November 19, 2025 | 334.88 |
| November 18, 2025 | 345.07 |
| November 17, 2025 | 342.02 |
| November 14, 2025 | 347.70 |
| November 13, 2025 | 345.81 |
| November 12, 2025 | 352.43 |
| November 11, 2025 | 349.49 |
| November 10, 2025 | 335.72 |
| November 07, 2025 | 321.95 |
| November 06, 2025 | 325.31 |
| November 05, 2025 | 334.98 |
| November 04, 2025 | 341.18 |
| November 03, 2025 | 351.80 |
| October 31, 2025 | 363.68 |
| October 30, 2025 | 369.67 |
| October 29, 2025 | 363.57 |
| October 28, 2025 | 365.46 |
| October 27, 2025 | 371.14 |
| October 24, 2025 | 352.43 |
| October 23, 2025 | 353.48 |
| October 22, 2025 | 348.33 |
| October 21, 2025 | 359.37 |
| October 20, 2025 | 361.57 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Biogen, Inc. | 1.702 |
| BioMarin Pharmaceutical, Inc. | 2.011 |
| Ionis Pharmaceuticals, Inc. | 20.42 |
| Regeneron Pharmaceuticals, Inc. | 2.548 |
Price to Book Value Related Metrics
| PS Ratio | 2.005 |
| PEG Ratio | -0.4328 |
| Price | 14.30 |
| Earnings Yield | -40.85% |
| Market Cap | 1.406B |
| PEGY Ratio | -0.4328 |